reports hero background
Updated: Sep 27, 2026
BRVE Logo

Braveheart Bio

NASDAQ:BRVE·Stock Analysis Report
Day Range
$16.89 - $18.99
Market Cap
1.80B
P/E Ratio
0.0000
Avg Value
$25.08
Year Range
$18.15 - $32.00
$18.60$1.19 (6.80%)
1
General Information
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases.

Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).

2
Braveheart Bio (BRVE) Stock Graph
3
How We Grade Braveheart Bio (BRVE)

We grade stocks based on past performance, their future growth potential, intrinsic value, dividend history, and overall financial health.

The chart below shows how we grade Braveheart Bio (BRVE) across the board compared to its closest peers.

4
Benzinga Edge Rankings

Benzinga Edge stock rankings give you four critical scores to help you identify the strongest and weakest stocks to buy and sell.

5
Peer Ratings

See how Braveheart Bio compares to its peers in these key performance metrics from Benzinga Rankings.

Top Peers
Value
Quality
Growth
Momentum
Short
Medium
Long
SEPNSepterna
N/A
N/A
N/A
99.18
ANIPANI Pharmaceuticals
52.59
N/A
52.59
13.62
ETONEton Pharmaceuticals
0.34
N/A
46.13
98.38
GHRSGH Research
N/A
N/A
N/A
34.85
Short: price trend over the last couple of months
Medium: price trend over the last couple of quarters
Long: price trend over the past year
Stock Score Locked: Want to See it?
Benzinga Edge Rankings give you vital metrics on any stock – anytime.
6
Future Growth
Our estimate of future price growth is based on an aggregation of 0 analyst ratings over the past 3 months and their 12-month price targets.

Below, you can see that analysts are estimating a 12-month price target range of $40.00 - $48.00 with an average of $45.25

126.14%
Expected movement for Braveheart Bio (BRVE) over the next 12 months
Based on these rankings

Recent Ratings for Braveheart Bio (BRVE)